Shuvo Roy | |
Birth Date: | 10 November 1969 |
Birth Place: | Dhaka |
Citizenship: | United States |
Fields: | Bioengineering, Biomedical MEMS, Pediatric Devices |
Workplaces: | University of California, San Francisco |
Alma Mater: | Mount Union College Case Western Reserve University |
Doctoral Advisor: | Mehran Mehregany |
Known For: | Co-invention of an implantable artificial kidney, medical MEMS |
Shuvo Roy is an American biomedical engineering known for his work with Bio-MEMS including the invention of an artificial kidney.[1] He currently serves as a professor at the Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco.
Shuvo Roy was born on 10 November 1969 in Dhaka (now in Bangladesh) to Ashok Nath Roy, a public health physician, and Ratna Roy, a teacher. His grandfather Nagen Dey was a professor of English at Sir Ashutosh Mukherjee College, Boalkhali. He hails from Chittagong Division, his paternal family being from Rosangiri in Fatikchhari and his maternal family being from Alkaran Ward.[2]
Roy started his elementary education in Siddheswari in Dhaka but moved with his father, mother and siblings to Uganda in 1974 where he received most of his education including at the Jinja Senior Secondary School (his mother being employed at the institution).
The family later moved to the US where Roy completed his education and earned his BS degree from University of Mount Union, Ohio in 1992. He then earned his MS degree in Electrical Engineering and Applied Physics from Case Western Reserve University in 1995. He went on to earn his PhD degree from the same school in 2001.[3]
Roy also spent a part of his childhood in India where most of his paternal family has settled (while his maternal family still resides in Bangladesh) and has been described as an Indian American.
He married Monica Matthews, an American, around 2003. He has two siblings: Joy Roy, a vascular surgeon, and Chaiti Roy, an anesthetic.
Roy has developed silicon nanopore membranes (SNM) to achieve high-efficiency blood ultrafiltration while selectively retaining specific solutes and serving as an immunoprotective barrier for encapsulated cells. The SNM are the fundamental underlying technology for the development of an implantable bioartificial kidney.
Using this technology, he has shown feasibility for an implantable bioartificial pancreas (iBAP). Previous attempts to develop a bioartificial pancreas have been severely limited by insufficient mass transfer and a limited supply of beta cells, but Roy says that ultra-high hydraulic permeability characteristic of the SNM will enable appropriate mass transport (especially oxygen, glucose, and insulin) to achieve optimal beta cell performance, while the ultra-selective pore characteristic of the SNM enable unprecedented immunoisolation. Also the iBAP can utilize a human stem cell derived fully functional beta cell that provides and unlimited supply of beta cells.
He is a founding member of the University of California, San Francisco Pediatric Device Consortium.[3]